Strand Life Sciences Pvt Ltd. entered into an agreement to acquire Triesta Sciences Inc. from HealthCare Global Enterprises Limited (BSE:539787) for INR 240 million on January 2, 2018. According to the terms of the consideration, Strand Life Sciences Pvt Ltd. will issues 9.14 million equity shares and 0.1 million series 1 preference shares to HealthCare Global Enterprises Limited, aggregating to 48.5% shareholding in Strand Life Sciences Pvt Ltd. post the transaction. For the financial year ended March 31, 2017, Triesta Sciences Inc reported external revenue from customers other than Strand was INR 71 million and net worth of Triesta Sciences was approximately INR 164 million. The transaction is not subject to any governmental or regulatory approvals. The transaction is expected to complete by January 15, 2018.